CharlestonPharma
Latest round
- Seed
Last raised
- Jan 2013
Total raised
- $1.6M
Investors
- 2
About CharlestonPharma
2C8.2C8. This antibody targets the nucleolin transporter on tumor cells, destabilizing oncogenic mRNAs, which leads to apoptosis in various cancer cell lines.2C8. The company may enter into collaborative agreements with pharmaceutical firms, involving upfront and milestone payments related to clinical trial progress, along with potential royalties on future sales.2C8 and exploring new partnerships within North America and Europe. Strategic initiatives include expanding into additional oncology markets and developing new therapeutic solutions to address unmet medical needs in cancer treatment.
Who invested in CharlestonPharma
2 investors across 1 round
See all investors in CharlestonPharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 29, 2013
Amount
$1.6M
Investors
Questions about CharlestonPharma
Who invested in CharlestonPharma?
CharlestonPharma has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CharlestonPharma raised?
CharlestonPharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CharlestonPharma last raise money?
CharlestonPharma's most recent round on record is a Seed, in Jan 2013.
What does CharlestonPharma do?
CharlestonPharma is a healthcare company.
Where is CharlestonPharma headquartered?
CharlestonPharma is headquartered in Charleston, US.
Which VCs invest in companies like CharlestonPharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at CharlestonPharma's stage. Their profiles are linked below.
VCs backing healthcare startups at Seed
Raising like CharlestonPharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.